These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16340641)

  • 21. Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization.
    Iwasa S; Ikeda M; Okusaka T; Ueno H; Morizane C; Nakachi K; Mitsunaga S; Kondo S; Hagihara A; Shimizu S; Satake M; Arai Y
    Jpn J Clin Oncol; 2011 Jun; 41(6):770-5. PubMed ID: 21459893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete regression of hepatocellular carcinoma under tamoxifen.
    Castéra L; Boige V; Rocher L; Duclos-Vallée JC; Fabre M; Buffet C
    Am J Gastroenterol; 2000 Mar; 95(3):827-9. PubMed ID: 10710095
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatocellular Carcinoma.
    Villanueva A
    N Engl J Med; 2019 Apr; 380(15):1450-1462. PubMed ID: 30970190
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.
    Barbare JC; Bouché O; Bonnetain F; Dahan L; Lombard-Bohas C; Faroux R; Raoul JL; Cattan S; Lemoine A; Blanc JF; Bronowicki JP; Zarski JP; Cazorla S; Gargot D; Thevenot T; Diaz E; Bastie A; Aparicio T; Bedenne L
    Eur J Cancer; 2009 Jul; 45(10):1788-97. PubMed ID: 19303768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune-based combinations for advanced hepatocellular carcinoma: shaping the direction of first-line therapy.
    Rizzo A; Ricci AD; Brandi G
    Future Oncol; 2021 Mar; 17(7):755-757. PubMed ID: 33508960
    [No Abstract]   [Full Text] [Related]  

  • 26. Regression of a hepatocellular carcinoma following treatment with octreotide and tamoxifen in a patient with advanced alcoholic cirrhosis.
    Senturk H; Canbakan B; Cumali R
    J Gastroenterol Hepatol; 2004 Jun; 19(6):719-20. PubMed ID: 15151636
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment outcomes with long acting octreotide in inoperable hepatocellular carcinoma: a local experience and review of literature.
    Gill ML; Atiq M; Sattar S; Khokhar N
    J Pak Med Assoc; 2005 Apr; 55(4):135-8. PubMed ID: 15918622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Guo TK; Hao XY; Ma B; Yang KH; Li YP; Li HL; Gu YH; Cai H; Liu YL; Li Y; Zhan WP
    J Cancer Res Clin Oncol; 2009 Dec; 135(12):1685-92. PubMed ID: 19536563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Octreotide therapy for hepatocellular carcinoma: a systematic review of the evidence from randomized controlled trials.
    Jia WD; Zhang CH; Xu GL; Ge YS; Wang W
    Hepatogastroenterology; 2010; 57(98):292-9. PubMed ID: 20583430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
    Wang C; Tang C; Tang L
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
    Cho Y; Lee JH; Lee DH; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS
    Oncotarget; 2017 Jul; 8(29):47555-47564. PubMed ID: 28548930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The results of a randomized study on the use of long-acting octreotide in hepatocellular carcinoma.
    Borbath I; Horsmans Y
    Hepatology; 2003 Feb; 37(2):477-8; author reply 478. PubMed ID: 12575712
    [No Abstract]   [Full Text] [Related]  

  • 34. Post-TACE combination therapy of heparin and octreotide results in decreased tumor metastasis in extrahepatic tumorigenesis.
    Jia W; Feng K; Fan P; Fan G; Yang S; Zhang T; Wei Q; Qian L
    Cell Biochem Biophys; 2012 Jan; 62(1):35-40. PubMed ID: 21822978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tamoxifen and hepatocarcinoma].
    Mondragón Sánchez R
    Rev Gastroenterol Mex; 1998; 63(3):169. PubMed ID: 10068765
    [No Abstract]   [Full Text] [Related]  

  • 36. Octreotide alone or in combination with rofecoxib as palliative treatment for advanced hepatocellular cancer.
    Treiber G; Röcken C; Wex T; Malfertheiner P
    Z Gastroenterol; 2007 May; 45(5):369-77. PubMed ID: 17503315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy.
    Saab S; McTigue M; Finn RS; Busuttil RW
    Exp Clin Transplant; 2010 Dec; 8(4):307-13. PubMed ID: 21143097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologic study of the effects of octreotide-LAR on growth hormone in unresectable and metastatic hepatocellular carcinoma.
    Attia S; Holen KD; Thomas JP; Richie K; Dzelak T; Teeter K; Warren D; Bilger A; Fine J; Eickhoff J; Drinkwater N; Mulkerin D; Morgan-Meadows S
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):44-54. PubMed ID: 18322441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sinonasal metastatic hepatocellular carcinoma.
    Huang HH; Chang PH; Fang TJ
    Am J Otolaryngol; 2007; 28(4):238-41. PubMed ID: 17606038
    [No Abstract]   [Full Text] [Related]  

  • 40. [Early diagnosis of hepatocellular carcinoma using computed tomography and magnetic resonance imaging].
    Moriyama N
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):1997-2002. PubMed ID: 8586920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.